Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation

Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation

Bibliographic Details
Main Authors:	Ang, C.H., Gan, G.G., Nadarajan, V.
Format:	Article
Published:	Ferrata Storti Foundation 2010
Subjects:	Q Science (General)